导读：新药创新已成大势所趋，从今年研发追逐的DPP-4抑制剂、替尼类抗肿瘤药等热点中我们就可见一斑，而在具有创新研发实力的企业中，不乏许多上市公司，大家的关注点自然离不开股市。今天我们就来理一理药品...
introduction: new drug innovation has become represent the general trend, we have remarkable from this research and development of DPP-4 inhibitors imatinib, chase class of antineoplastic drugs and other hot spots, and in with the strength of innovation development enterprises, many listing Corporation, the attention of nature cannot do without the stock market. Today we have to manage drug...
